[go: up one dir, main page]

NO20000330L - FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein - Google Patents

FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein

Info

Publication number
NO20000330L
NO20000330L NO20000330A NO20000330A NO20000330L NO 20000330 L NO20000330 L NO 20000330L NO 20000330 A NO20000330 A NO 20000330A NO 20000330 A NO20000330 A NO 20000330A NO 20000330 L NO20000330 L NO 20000330L
Authority
NO
Norway
Prior art keywords
lipid
protein
articles
procedure
production
Prior art date
Application number
NO20000330A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000330D0 (no
Inventor
Matthias Andersson
Dorota Johansson
Percy Li
Bjoern Norrlind
Bengt Westgren
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of NO20000330D0 publication Critical patent/NO20000330D0/no
Publication of NO20000330L publication Critical patent/NO20000330L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20000330A 1997-07-22 2000-01-21 FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein NO20000330L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702776A SE9702776D0 (sv) 1997-07-22 1997-07-22 Method of preparing pharmaceutical compositions
PCT/SE1998/001407 WO1999004761A1 (fr) 1997-07-22 1998-07-22 Procede de preparation de compositions pharmaceutiques de particules lipidiques renfermant un agent lipidique et une proteine

Publications (2)

Publication Number Publication Date
NO20000330D0 NO20000330D0 (no) 2000-01-21
NO20000330L true NO20000330L (no) 2000-03-21

Family

ID=20407807

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000330A NO20000330L (no) 1997-07-22 2000-01-21 FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein

Country Status (12)

Country Link
EP (1) EP1014947B1 (fr)
JP (1) JP3813439B2 (fr)
AT (1) ATE289806T1 (fr)
AU (1) AU744738B2 (fr)
CA (1) CA2297924C (fr)
DE (1) DE69829191T2 (fr)
ES (1) ES2236919T3 (fr)
NO (1) NO20000330L (fr)
NZ (1) NZ502840A (fr)
PT (1) PT1014947E (fr)
SE (1) SE9702776D0 (fr)
WO (1) WO1999004761A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002537102A (ja) 1999-02-26 2002-11-05 カイロン コーポレイション 吸着された高分子および微粒子を有するミクロエマルジョン
JP2003517889A (ja) * 1999-12-22 2003-06-03 サージカル シーランツ， インコーポレイテッド 組織の漏出を封止するための方法および組成物
ATE381328T1 (de) * 2000-02-02 2008-01-15 Univ Florida State Res Found Heterosubstituierte taxan-c10-acetate als antitumormittel
US6514523B1 (en) * 2000-02-14 2003-02-04 Ottawa Heart Institute Research Corporation Carrier particles for drug delivery and process for preparation
AU5711501A (en) * 2000-04-20 2001-11-07 Rtp Pharma Inc Improved water-insoluble drug particle process
US6599441B1 (en) 2000-07-18 2003-07-29 Emerald Biostructures, Inc. Crystallization solutions
KR101186210B1 (ko) 2002-12-03 2012-10-08 블랜체트 록펠러 뉴로사이언시즈 인스티튜트 혈뇌장벽을 통과하는 물질 수송용 인공 저밀도 지단백질 운반체
US7803400B2 (en) 2002-12-03 2010-09-28 Blanchette Rockefeller Neurosciences Institute Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
CA2521051C (fr) 2003-04-04 2012-03-20 Pfizer Products Inc. Emulsions microfluidifiees d'huile dans l'eau et compositions de vaccins
JP4050784B2 (ja) * 2005-02-03 2008-02-20 株式会社Ｎｒｌファーマ マトリックス型腸溶性・徐放性組成物
JP4970424B2 (ja) * 2005-03-28 2012-07-04 リゲロン アイエヌシー 蛋白質を包囲するナノリポソームの製造方法及び蛋白質−包囲ナノリポソーム
WO2007076452A1 (fr) * 2005-12-29 2007-07-05 Invitrogen Corporation Compositions et procédés pour améliorer la résolution de biomolécules séparées sur des gels de polyacrylamide
EP1915986A1 (fr) * 2006-10-23 2008-04-30 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Fomulations lipidiques comprenant des facteurs de croissance
CH715456B1 (de) 2007-04-27 2020-04-30 Mibelle Ag Kosmetisches Produkt zur topischen Anwendung für den Schutz und die Erneuerung von Hautstammzellen, welches sich von dedifferenzierten Pflanzenzellen ableitet.
US8071759B2 (en) 2008-07-18 2011-12-06 Affymetrix, Inc. Water soluble cholesterol derivatives
WO2010057203A2 (fr) 2008-11-17 2010-05-20 The Board Of Regents Of The University Of Texas System Particules de hdl pour administration d'acides nucléiques
KR101689787B1 (ko) * 2009-08-31 2016-12-26 나노캐리어 가부시키가이샤 입자 조성물 및 이를 가진 의약 조성물
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
WO2025215934A1 (fr) * 2024-04-09 2025-10-16 コニカミノルタ株式会社 Dispositif de prédiction, procédé de prédiction de distribution granulométrique pour un dispositif de prédiction, et programme de prédiction de distribution granulométrique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128318A (en) * 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
IL86799A (en) * 1987-07-02 1993-03-15 Kabi Pharmacia Ab Method and device for injection
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins

Also Published As

Publication number Publication date
EP1014947A1 (fr) 2000-07-05
AU744738B2 (en) 2002-02-28
WO1999004761A1 (fr) 1999-02-04
ES2236919T3 (es) 2005-07-16
NO20000330D0 (no) 2000-01-21
DE69829191D1 (de) 2005-04-07
AU8371898A (en) 1999-02-16
DE69829191T2 (de) 2005-07-21
CA2297924A1 (fr) 1999-02-04
NZ502840A (en) 2002-08-28
JP3813439B2 (ja) 2006-08-23
JP2001510786A (ja) 2001-08-07
EP1014947B1 (fr) 2005-03-02
CA2297924C (fr) 2007-04-10
ATE289806T1 (de) 2005-03-15
PT1014947E (pt) 2005-05-31
SE9702776D0 (sv) 1997-07-22

Similar Documents

Publication Publication Date Title
NO20000330L (no) FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein
AU649973B2 (en) Aromatic amine compounds, their method of preparation and pharmaceutical compositions in which they are present
CZ58196A3 (en) Naphthyl derivative, process of its preparation, pharmaceutical composition containing and intermediate for preparing thereof
DE69802005D1 (de) Kombination aus prolaminen und polaren pflanzlichen lipiden, verfahren zu deren herstellung sowie deren verwendungen
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
ATE34078T1 (de) Arzneiform zur oralen verabreichung sowie verfahren zu deren herstellung durch gefriertrocknen einer oel-in-wasser-emulsion.
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
ZA961898B (en) Novel melatonin-antagonist beta-carboline derivatives and analogues thereof containing naphthalenic structure process for their preparation and their medicinal products
IL82231A0 (en) 1-hydroxy-2-pyridones,process for their preparation,and pharmaceutical compositions which contain them and intermediates formed in the preparation of the 1-hydroxy-2-pyridones
IL83357A (en) Renin-inhibiting peptides, process for their preparation, pharmaceutical compositions containing them, and their use
DE3767998D1 (de) Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
BR9508034A (pt) Processo e aparelhagem para a preparação de uma unidade comestível que se dissolve rapidamente a referida unidade composição para liberar um ingrediente ativo processo para administração de um ingrediente ativo a um hospedeiro humano e produto provisório para fabricação da unidade comestível
HUT40677A (en) Process for preparing water-soluble platinum compounds and pharmaceutical preparations comprising these compounds as active substance
FI921562A7 (fi) Gem-difosfonihapot, menetelmä niiden valmistamiseksi ja farmaseuttiset koostumukset, jotka sisältävät niitä
AU583255B2 (en) New benzenesulfonyl-lactams, process for their preparation and their use as active substances of pharmaceutical compositions
AU586410B2 (en) New cyclic benzenesulfonamides, process for their preparation and their use as active substance of pharmaceutical compositions
DK0740547T3 (da) Liposomer indeholdende deri indkapslede proteiner, fremgangsmåde til deres fremstilling, samt farmaceutiske og kosmetiske p
DE3768084D1 (de) Rekonstituiertes nahrungsmittel, verfahren und mischer zu seiner herstellung.
AU6551198A (en) Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
HUT44764A (en) Process for producing new sulfonamidoethyl derivatives and pharmaceutical preparations comprising them as active substance
HRP960063B1 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
SE8405118D0 (sv) 4-kloro-furo-(3,4-c)-pyridin-derivat forfarande for framstellning derav och terapeutiska kompositioner innehallande dem
FR2595703B1 (fr) Nouveaux phospholipides, leur procede et les intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
PL317397A1 (en) Novel substituted derivatives of chromanylosulphonylurea and chromanylosulphonylthiourea, method of obtaining them, their application in production of pharmaceutic preparations and pharmaceutic preparation as such
DZ2827A1 (fr) Nouveaux 19-nor stéroïdes 17-halogéneés, procédé et intermédiares de préparation, application commemédicaments et compositions pharmaceutiques les r enfermant.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application